GH509

· 1Globe Biomedical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GH509, covering 2023-03-28 to 2023-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD [Phase 1, Phase 2]

See pricing